United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Levo gets FDA fast track status for LV-101 in Prader-Willi syndrome US biotech company Levo Therapeutics has been granted fast track designation for LV-101 (intranasal carbetocin) from the US… bypharmanewsdailyNovember 19, 2019
